BIM
CBPO

BlackRock Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlackRock Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$257K Sell
2,391
-3,110
-57% -$364K ﹤0.01% 3196
2016
Q3 		$685K Buy
5,501
+4,015
+270% +$474K ﹤0.01% 2881
2016
Q2 		$158K Buy
+1,486
New +$173K ﹤0.01% 3291

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock Investment Management's CBPO Position: Q4 2016 in Review

BlackRock Investment Management reduced its China Biologic Products Holdings, Inc. (CBPO) stake by 57% in Q4 2016, selling an estimated $364K and leaving 2,391 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3196.

BlackRock Investment Management first reported a position in CBPO in Q2 2016 and has held it in 3 quarters since. The position peaked at $685K in Q3 2016. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

  • BlackRock Investment Management held 2,391 shares of China Biologic Products Holdings, Inc. worth $257K as of Q4 2016.
  • BlackRock Investment Management sold 3,110 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $364K.
  • China Biologic Products Holdings, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3196 holding.
  • BlackRock Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Investment Management's China Biologic Products Holdings, Inc. position peaked at $685K in Q3 2016.
  • 143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.